S02 Drugs and Dosage Forms II Learning Objectives

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/56

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:06 AM on 8/25/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

57 Terms

1
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What is the United States Pharmacopeia (USP)?

science-based public health organization.

2
New cards


Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What publication does the USP produce?

The USP-NF.

3
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What does the Greek word "pharmakon" mean?

Drug

4
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What does the Greek word "poiein" mean?

Make

5
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What does the term pharmacopeia suggest?

Any recipe, formula, or other standards required to prepare a drug.

6
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

Who originally edited the National Formulary (NF)?

Pharmacists

7
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

Which act recognized the USP/NF as the official compendia of drug standards in 1938?

The Federal Food, Drug, and Cosmetic Act (FD&C).

8
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

How frequently is the USP published?

Annually

9
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What information do the formulas, monographs, and reference books in the USP-NF describe?

Standards that manufacturers and pharmacists should maintain when preparing drug products.

10
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What is a drug formulation or formula?

A recipe for the preparation of a drug product.

11
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What two main components are specified under the name and quantities of ingredients in a drug formula?

Active ingredients and excipients.

12
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What details regarding processing are included in a drug formulation?

The mixing sequence and processing steps.

13
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What is the official compendium of drug standards in the United Kingdom?

The British Pharmacopeia (BP).

14
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What is the official compendium of drug standards in Europe?

The European Pharmacopeia (EP)

15
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What is the official compendium of drug standards in Japan?

The Japanese Pharmacopeia (JP).

16
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What section was added to the FD&C Act by the Food and Drug Administration Modernization Act (FDAMA) of 1997?

Section 503A [Practice of Pharmacy Compounding].

17
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What exemption regarding new drug applications does Section 503A grant to pharmacy compounded products?

Exemption from FDA approval under NDAs or ANDAs.

18
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What labeling exemption does Section 503A grant to compounded drug products?

Exemption from labeling drugs with adequate directions for use.

19
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What manufacturing exemption does Section 503A grant to compounded drug products?

Exemption from Current Good Manufacturing Practices (cGMP) requirements.

20
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What are Current Good Manufacturing Practices (cGMP)?

General practices observed during manufacturing to ensure products meet appropriate and consistent quality standards.

21
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

For whom must a drug product be compounded to qualify for Section 503A exemptions?

An identified individual patient based on a valid prescription order.

22
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

Who must perform the compounding for a product to meet Section 503A exemptions?

licensed pharmacist.

23
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

Which chapters must pharmacy compounding comply with to receive Section 503A exemptions?

The United States Pharmacopeia (USP) chapters on pharmacy compounding.

24
New cards

Learning Objective 1: Recognize and understand the role of official compendia in setting drug quality standards

What restriction does Section 503A place on compounding commercial drug products?

Pharmacists must not regularly or in inordinate amounts compound products that are essentially copies of commercial drugs.

25
New cards

Learning Objective 2: Summarize the steps involved in the drug approval process

What are the three main stages of the pharmaceutical product approval process?

Early Discovery and Pre-Clinical Development, Clinical Development, and Commercialization/post-marketing surveillance.

26
New cards

In what subjects is pre-clinical drug development performed?

Animals

27
New cards

In what subjects are clinical development studies (Phases I, II, and III) performed?

Humans

28
New cards

What application must be filed before testing a drug in humans for the first time?

New Drug (IND) application

29
New cards

What application is submitted to the FDA to market a new drug after clinical trials?

New Drug Application (NDA).

30
New cards

Who participates in Phase I clinical trials?

A small number of healthy volunteers (20 to 100 people).

31
New cards

What are the primary aims of Phase I clinical trials?

To learn how to administer the drug safely, monitor side effect profiles, and obtain initial dosing information.

32
New cards

Who participates in Phase II clinical trials?

Several hundred people with the target disease.

33
New cards

What is the primary aim of Phase II clinical trials?

To determine patients' responses to the drug through proof-of-concept studies.

34
New cards

What key decision is made at the end of Phase II clinical trials?

Whether a useful therapeutic response exists to warrant Phase III trials.

35
New cards

Who participates in Phase III clinical trials?

large number of participants (several hundreds to thousands).

36
New cards

Why are Phase III clinical trials conducted across multiple study sites?

To confirm drug effectiveness in large, multicenter clinical trials.

37
New cards

What is Phase IV of clinical development?

Post-approval studies or post-marketing surveillance

38
New cards

Why is Phase IV post-marketing surveillance necessary?

To detect rare adverse drug reactions (occurring in <1 in 3000 to 5000 patients) not found in earlier phases.

39
New cards

Where do healthcare professionals report adverse drug events to the FDA?

FAERS or the MedWatch program.

40
New cards

What action may the FDA take if post-marketing trends show severe adverse drug reactions?

Require additional data, mandate new clinical trials, revise drug labeling, issue warnings, or remove the product from the market.

41
New cards

What is the definition of a drug dose?

An amount of drug sufficient to produce a therapeutic response without toxic effects

42
New cards

Learning Objective 3: Differentiate between brand and generic drug products

What is a brand-name drug product?

An innovator's product protected by an exclusive patent.

43
New cards

What type of drug name is officially registered as a trademark by a company?

proprietary (Brand) name.

44
New cards

Which 1984 law allowed companies to copy innovator drugs once their patents expire?

The Hatch-Waxman Act.

45
New cards

What is a generic drug product?

A product chemically identical to the original branded drug marketed after patent expiration.

46
New cards

What type of drug name is standardized and recognized as a common name?

A non-proprietary (Generic) name.

47
New cards

Which two organizations establish standardized non-proprietary drug nomenclature?

The USAN Council and the World Health Organization (WHO).

48
New cards

Which application must be submitted to the FDA for generic drug approval instead of an NDA?

Abbreviated New Drug Application (ANDA).

49
New cards

What requirement must generic drugs satisfy in place of preclinical and clinical safety/efficacy studies?

A bioequivalence study showing equivalent efficacy to the brand counterpart.

50
New cards

What features must be identical between a generic product and its brand counterpart?

The active ingredient(s), strength, and dosage form.

51
New cards

What is an unbranded (ordinary) generic drug?

A generic drug made by a company other than the brand owner and approved via an ANDA.

52
New cards

What is an authorized generic drug?

A drug identical to the brand product in all aspects except that it does not use the brand name.

53
New cards

Under which application is an authorized generic drug marketed?

The original brand drug's NDA

54
New cards

When can an authorized generic be sold relative to patent expiration?

Before drug patent expiration.

55
New cards

When can unbranded and branded generics be sold relative to patent expiration?

After branded drug patent expiration.

56
New cards

What is a branded generic drug?

A generic drug that has been given a proprietary market name and requires an ANDA.

57
New cards

How does the cost of an unbranded generic typically compare to branded or authorized generics?

Unbranded generics are typically cheaper